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Abstract 
Objective: To identify service gaps by mapping accessibility to 
diagnostic sleep studies across Australia using a Geographic 
Information System (GIS).
Methods: Census-level data stratified by statistical areas were 
mapped to measure accessibility to polysomnography (PSG) based 
on geographical location of patients. All adult publicly funded 
home and laboratory-based PSG performed in Australia in 2012 
were mapped to statistical areas based on patient address at the 
time of the sleep study.
Results: Sleep health care is extremely under-resourced in central 
and northern Australia. For those living in areas classified as remote 
and very remote, geographical distance appears to be a barrier to 
the accessibility of specialist sleep services.
Conclusions: Remote and very remote communities continue to 
experience inequity in health care in general and in accessibility 
to specialist services in particular. Attention needs to be given to 
barriers which may limit equitable accessibility.
Implications: Residing in remote communities with limited or no 
public transport options is likely to have a particularly significantly 
impact on Aboriginal and Torres Strait Islander peoples’ ability to 
access PSG.
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Introduction
To ensure equitable and efficient access to health care it is first 
necessary to understand how access varies across geography. 
Geographic Information Systems (GIS) can be used to assess access 
to health care using a variety of methods, for example: to measure 
access to health care based on distance to nearest outpatient facility, 
nearest hospital and number of  annual hours of consultation with 
medical practitioners per person [1]; to measure geographical 
access to a range of community resources linked to health based 
on distance from resources [2]; to measure accessibility to general 
practitioner (GP) surgeries based on transport by bus and car [3]; 
the relationships between social disadvantage and the quality and 
quantity of GP services available [4]; and to determine health care 
access by mapping the home location of community health centre 
patients [5]. 
There are currently no published data regarding the accessibility 
to diagnostic sleep studies or polysomnography (PSG) services 
across different Australian geographic locations. The purpose of 
this study was therefore to identify and summarise how access to 
Medicare funded PSG varied by patient location stratified by census 
statistical areas throughout Australia. This study builds on our work 
identifying trends in PSG provision in Australia over time and the 
impact of the introduction of home-based sleep studies [6]. Such 
work, by identifying gaps in service provision and unmet need, can 
facilitate the realignment or expansion of diagnostic sleep services 
for all Australians no matter where they live. 
Background
Obstructive sleep apnoea (OSA) is the most common form of 
sleep-disordered breathing (SDB) in Australia and elsewhere. OSA 
consists of recurrent episodes of upper airway collapse during 
sleep. In turn, this is associated with waking unrefreshed and 
excessive daytime sleepiness as sleep is disturbed by frequent brief 
arousals to initiate breathing [7]. OSA occurs when the muscles in 
the back of the throat relax which narrows the airway, reducing air 
intake and the level of oxygen in the blood. At this point the brain 
briefly rouses the person from sleep to reopen the airway. Arousals 
may occur many times per hour impairing the restful phases of 
sleep and leaving sufferers feeling excessively sleepy throughout 
the day. People who are overweight or obese have a larger neck 
circumference, smoke or consume alcohol, are at greater risk of 
OSA [8]. OSA impacts on overall patient health and well-being 
due to an increased risk of hypertension, diabetes, cardiovascular 
disease, stroke, daytime sleepiness, motor vehicle accidents, and 
diminished quality of life [8-10]. The standard treatment option for 
moderate to severe OSA is a continuous positive airway pressure 
(CPAP) machine that uses mild air pressure to keep the airways 
open whilst the patient sleeps.
A recent Australian population-based cohort study estimated a 
high prevalence of OSA among males, with risk increasing with 
older age (<50 yrs 41 2%, >70 yrs 63.2%) [11]. Although there is 
no OSA prevalence data available for the Australian Indigenous 
population, a recent review of OSA in adult Indigenous populations 
in Canada, USA and New Zealand found Indigenous peoples have 
a higher prevalence of OSA and a greater severity. However, the 
greater prevalence and severity is attributed to increased risk factors 
for OSA (obesity, alcohol and tobacco use) and higher levels of 
co-morbid medical conditions associated with low socioeconomic 
status rather than Indigeneity [12]. The Indigenous population is 
much younger than the non-Indigenous population (2010 median 
age: non-Indigenous = 32, Indigenous = 17) but obesity rates for 
Indigenous Australians are significantly higher than rates for non-
Indigenous people in almost every age group [13]. The prevalence 
of OSA is predicted to increase as the Australian population ages 
and the prevalence of obesity and metabolic syndrome increases 
[11]. Given the significantly increased rates of obesity, Indigenous 
people are at risk of a greater burden of disease.  Diagnosis of 
OSA requires PSG, a test which can either be performed at a sleep 
laboratory or at home using specialised monitoring equipment. 
PSG is the ‘gold standard’ method of OSA diagnosis [14]. 
Access to health services is complex and depends in part on the 
availability and adequate supply of health services. In the context 
of PSG access, equity of access is measured in terms of accessibility 
to this diagnostic service. Accessibility refers to the relative ease by 
which health care can be reached from a given location [16]. Access 
to health services varies across space, affected by the location of 
health services (supply) and patient location and disease burden 
(demand). Accessibility depends not only on the supply of 
resources in a community, but also on the supply of such resources 
in neighbouring communities and the distance and ease of travel 
between them [16]. 
Geographical access is a function of the time and distance needed 
to travel to access health care [17]. Geographical access also 
includes factors such as the mode and cost of travel and access 
to transportation. In regional and remote Australia, seasonal road 
access, variable road quality and greater distances to regional 
centres means the type of transportation required (road versus air 
or sea) can also influence access and cost. 
The extent a population gains access to health services depends 
on overcoming financial, organisational, cultural or social barriers 
which may limit the utilisation of such services [15]. Accessibility 
of health care for Indigenous peoples and other disadvantaged 
groups within Australian society also involves other ‘costs’ to 
family (arranging care of dependents, time away from family and 
other responsibilities), work (taking time off work, managing the 
stigma associated with asking for time off work, having to take 
leave without pay if on casual employment or if the employment 
contract does not provide for paid leave), and other significant 
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stresses associated with transportation, accommodation, food 
etc. Importantly, issues related to engagement with health care 
professionals and clinicians who are unknown to the patient and/
or recalling past negative experiences with health services also 
play a role.
Australians residing in regional, rural and remote areas do not have 
equal access to health services compared with those residing in 
metropolitan areas due to a lower supply of health care facilities 
and health care providers and greater distances required to travel 
to access care [18]. 
Australia is a vast country, the sixth largest in the world, with a 
total area of 7,686,850 square kilometres and a population of 
approximately 23 million [19]. Two-thirds of Australia’s population 
reside within major capital cities and metropolitan areas, as 
depicted in Figure 1(a). 
Figure 1(a)  Population density per square km throughout Australia 
(Australian Bureau of Statistics, 2013)
Source: Australian Bureau of Statistics – 3218.0 (http://www.abs.gov.au/ausstats/abs@.
nsf/products/3218.0~2012-13~Main+Features~Main+Features)
Figure 1(b)  Home-based PSG (12250) per 100,000 Medicare enrolees in 
2012
Figure 1(c)  Laboratory-based PSG (12203) per 100,000 Medicare enrolees 
in 2012
Figure 1(d)  Total PSG per 100,000 Medicare enrolees in 2012
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The Accessibility Remoteness Index Australia (ARIA) 2006 is a 
measure of geographic remoteness based on road distance from 
localities to service centres with a population greater than 5,000. 
The ARIA defines five categories of remoteness: highly accessible, 
accessible, moderately accessible, remote, very remote. ARIA 
categories reflect the ease or difficulty people face accessing 
services in non–metropolitan Australia (Figure 2). 
Figure 2  Accessibility Remoteness Index Australia (ARIA) 2006
Source: Australian Government department of Health (www.health.gov.au/internet/
publications/publishing.nsf/Content/ARIA-Review-Report-2011~ARIA-Review-Report-
2011-2~ARIA-Review-Report-2011-2-2-3)
The majority of Australia is classified as remote or very remote, 
and predominately consists of sparsely populated desert regions. 
Around one-quarter of Australia’s Indigenous population (total 
Indigenous population at 2011 census n = 548,370) reside in the 
most remote and sparsely populated areas of Australia (www.abs.
gov.au). Of the Indigenous population, 27% reside in the Northern 
Territory, 4% in Tasmania, 3.6% in Queensland, 3.1% in Western 
Australia, 2.5% in New South Wales, 1.9% in South Australia, 1.5% 
in Australian Capital Territory and 0.7% in Victoria [20]. 
Remoteness of residence disproportionately impacts on 
accessibility of health care services for this population. Indigenous 
Australians residing in remote areas cite transport, distance and 
lack of health services in the area as the predominant difficulties 
they experience in accessing health care [21]. 
The burden of chronic disease in Australian Indigenous peoples 
is very high and Indigenous people have the highest rates of 
cardiovascular, respiratory, diabetes and renal morbidity compared 
with non-Indigenous peoples [22]. It is estimated that Indigenous 
Australians suffer a two-and-a-half times greater burden of disease 
than non-Indigenous Australians [23]. Indigenous Australians 
also have a higher prevalence of long-term chronic health 
conditions compared with non-Indigenous Australians [20,23] 
and chronic conditions such as heart and kidney disease, diabetes 
and respiratory diseases contribute to much of the ill health 
experienced by Indigenous people [21]. 
Geographic isolation, lack of health care services and accessibility 
issues are multidimensional problems [24]. There is a growing 
recognition that geographical inequalities to health care access 
intersect with those based on socioeconomic status and ethnicity 
leading to complex patterns of disadvantage [25]. Indigenous 
health status is closely related to social determinants of health; 
lower socioeconomic status, lower household incomes, and lower 
educational achievement is related to poorer health [21]. People 
living in non-metropolitan Australia are likely to have a lower 
income, lower socio-economic status, and lower educational 
achievement than people living in metropolitan Australia [24]. Thus 
greater levels of remoteness may lead to a clustering of adverse 
health determinants and risk factors which may in turn lead to a 
greater burden of disease which can compound the disadvantage 
inherent with poorer health service access. 
Given that Indigenous Australian suffer a greater burden of disease 
than non-Indigenous Australians, have a higher prevalence of 
risk factors for OSA, and OSA increases the risk of hypertension, 
diabetes, cardiovascular disease, and stroke, it is important that 
Indigenous Australians have equitable access to specialist OSA 
diagnostic and treatment services to improve their overall health 
and quality of life, and reduce the health disparity between 
Indigenous and non-Indigenous peoples. 
The objective of this study was to examine geographic variations 
in specialist sleep service utilisation, and identify gaps in service 
accessibility by describing access to laboratory-based and home-
based sleep studies across all Australian states and territories. The 
secondary aim was to use this information to highlight areas in 
Australia that may benefit from initiatives to enhance access to 
in-home and/or laboratory-based PSG. 
Methods
Australia has eight jurisdictions, six states and two territories, 
comprising Queensland (QLD), New South Wales (NSW), Victoria 
(VIC), Tasmania (TAS), South Australia (SA), Western Australia 
(WA), the Australian Capital Territory (ACT), and the Northern 
Territory (NT). Whilst there are other Australian Territories (Lord 
Howe Island, Antarctica etc.), these were excluded from analysis. 
Medicare is Australia’s national health care system and covers 
all citizens and permanent residents of Australia. Medicare is 
responsible for reimbursing to health practitioners or patients the 
costs of consultations, tests related to medical diagnosis, surgical 
procedures and hospitalisations. It is estimated that Medicare 
funds approximately 90% of all PSGs performed in Australia [26]. 
The Medicare Australia website provides statistical information 
regarding publically funded PSG in absolute numbers and per 
100,000 Medicare enrolees, stratified by state and territory, per 
calendar and financial year (www.medicareaustralia.gov.au). This 
data is presented in Table 1.
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The Medicare billing item number 12203 is used to designate a 
specified diagnostic service involving overnight investigation for 
SDB for an adult aged 18 years or over, in a sleep laboratory where 
a technician is in continuous attendance under the supervision of a 
qualified sleep medicine practitioner. Medicare billing item 12250 
is for overnight investigation of SDB for an adult aged 18 years 
or over, where the monitoring occurs in the patient’s home. In 
Australia, Medicare-funded in-home PSG is required to incorporate 
a minimum of seven physiological parameters: continuous electro-
encephalogram (EEG); continuous electro-cardiogram (ECG; 
airflow; thoraco-abdominal movement; oxygen saturation; and at 
least two or more of the following: electro-oculogram (EOG); chin 
electro-myogram (EMG); body position [27].
Data relating to in-home and in-laboratory PSG performed in 
2012 were obtained from Medicare Australia by request with a fee 
attached. The provided data had been divided geographically by 
statistical local areas (SA3s) in each state and territory based on 
patient postcodes at the time the claim was made for the PSG service. 
Statistical Areas Level 3 (SA3s) are geographical areas designed to 
provide a regional breakdown of Australia and represent regions of 
between approximately 30,000 people and 130,000 (www.abs.gov.
au). Medicare data were mapped to statistical areas in each state 
and territory per 100,000 adult population using GIS to illustrate 
accessibility to diagnostic sleep services across Australia. GIS is an 
information system designed to integrate, analyse and display all 
types of spatial or geographical data. GIS allows users to edit data 
in maps and represent the results graphically. Medicare data were 
converted to rates per 100000 adult population with the numerator 
being the absolute number of PSGs performed in 2012 in each 
statistical area (SA3), and the denominator as the adult population 
(≥ 18 years) in each statistical area based on data from the 2011 
Australian census. Utilisation rates were expressed per 100000 
adult population in each statistical area. This data is represented in 
Figure 1 (b), (c) and (d).
For the purpose of this study, the following qualitative cut-off 
points will be used when discussing PSG accessibility: low 
accessibility = < 200 sleep studies per 100,000 adult population, 
moderate accessibility = 200 - 400 sleep studies per 100,000 adult 
population, high accessibility = ≥ 400 sleep studies per 100,000 
adult population.
Results
Table 1 shows freely-available online Medicare data for in-home 
and in-laboratory PSG conducted in 2012 per 100,000 Medicare 
enrolees divided by Australian jurisdiction. In 2012, an average of 
575 adult PSG per 100,000 Medicare enrolees, 132,227 PSG in total, 
were performed across Australia [6]. State and Territory stratified 
data shows the highest rates of sleep studies per 100,000 Medicare 
enrolees occurred in Queensland (823), South Australia (601), the 
Australian Capital Territory (592), and New South Wales (578). The 
highest rate of in-laboratory PSGs per 100,000 Medicare enrolees 
occurred in Queensland (671), and the lowest in the Northern 
Territory (201). The highest rate of in-home PSG per 100,000 
Medicare enrolees occurred in the Australian Capital Territory (288) 
and the lowest in Tasmania (51]. Although the Medicare website 
provides aggregated jurisdictional data, it does not stratify data 
beyond the state and territory level.  
Table 1  Medicare Australia 2012 adult PSG provision data stratified by Australian jurisdiction
2012 Service State
NSW VIC QLD SA WA TAS ACT NT Total
Per100,000 
Medicare 
enrolees
12203
In-laboratory 
PSG
360 316 671 389 262 283 304 201 399
12250
In-home PSG
218 141 152 212 159 51 288 165 176
Total 
studies/100000
578 457 823 601 421 334 592 366 575
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In-home PSG
Figure 1(b) demonstrates the distribution of in-home PSG per 
100,000 adult population, divided by statistical areas (the borders 
for each statistical area have been removed to prevent them 
obscuring the colour coded data in and around capital cities). 
Access to in-home PSG was predominantly concentrated around 
metropolitan areas, with moderate access in regional areas of 
South Australia, Victoria, New South Wales, and coastal northern 
Queensland. Accessibility to in-home PSG was low (< 200 sleep 
studies per 100,000 adult population) across the rest of Australia, 
particularly Western Australia, Northern Territory, inner Queensland 
and Tasmania. Figure 1(a) highlights that a more remote place of 
residence resulted in reduced accessibility to in-home PSG even 
after controlling for the associated lower population.
In-laboratory PSG
Figure 1(c) depicts accessibility to in-laboratory PSG per 100,000 
adult population, stratified by statistical area. As with in-home 
PSG, high accessibility was concentrated around the metropolitan 
areas of Adelaide, Melbourne, Sydney, and Brisbane. Although 
Queensland delivered the highest rate of in-laboratory PSG per 
100,000 adult population (item number 12203), high accessibility 
(≥ 400 sleep studies per 100,000 adult population) to sleep services 
outside of the metropolitan area was mainly confined to major 
coastal regional centres located in northern Queensland.
Combined data
Figure 1(d) shows combined PSG utilisation data for in-home and 
in-laboratory sleep studies (items 12203 and 12250). This map 
clearly depicts areas where accessibility to PSG is limited. The 
resident population of the Northern Territory had limited access to 
PSG (< 200 sleep studies per 100,000 adult population), as did a 
majority of statistical areas in Tasmania. Large areas of Remote and 
Very Remote (ARIA) sites in Western Australia and South Australia 
also had limited access. The population centre of Brisbane in 
Queensland and east coast regional cities were well served with 
high accessibility (≥ 400 sleep studies per 100,000 adult population) 
to PSG. Nonetheless, the population of Cape York, the northern 
peninsula of Queensland, and central and western Queensland had 
very limited access to specialist sleep services. 
Access to diagnostic sleep service did not relate to population 
density or distance from large centres alone. Sites adjacent to the 
large centre of Sydney in NSW demonstrated relatively limited 
access (200 - 400 sleep studies per 100,000 adult population) whilst 
more remote areas adjacent to the South Australia-Victoria border 
had a higher level of accessibility (≥ 400 sleep studies per 100,000 
adult population). 
Discussion
This is the first study to map accessibility to sleep studies in 
Australia or throughout the world. We have demonstrated how 
GIS mapping can be used to analyse accessibility to PSG based on 
geographic utilisation data. Such health service information can 
be used by health service funders and planners to optimise the 
location of future health services, to focus initiatives to address 
health service gaps and to evaluate the benefit of such initiatives 
on addressing geographical barriers to health service accessibility 
[28]. Although people are more likely to utilise health care services 
that are conveniently located in relation to their home, work or 
shopping activity patterns, most people are willing to travel further 
to obtain specialised diagnostic services or health care [25]. The 
key is ensuring such services are reasonably accessible and that 
the cost and reimbursement systems for accessing such services 
do not create significant barriers for people living outside major 
urban centres. Nonetheless this does not address the complexity 
of issues and other ‘costs’ related to health care accessibility for 
Indigenous peoples and other disadvantaged groups.
The geographic location of those accessing sleep studies is 
concentrated in the more densely populated areas around the 
coastline, and South East Australia in particular. Figure 1(d) 
demonstrates that for the majority of Australians residing in 
metropolitan areas or adjacent to most State or Territory capitals, 
geographical distance is not a barrier to accessibility for PSG. Figure 
1(d) also demonstrates there are significant areas where this is not 
the case. PSG is extremely under-utilised in central, northern and 
western Australia; areas outside the major population centres [29]. 
However, without OSA prevalence data for Indigenous Australians 
there is no evidence available to indicate the level of services 
required in these areas. 
For those living in areas classified as Remote and Very Remote 
(ARIA), geographical distance appears to be closely connected with 
PSG accessibility. The distance travelled by people in such areas 
to access health care adds to the disadvantages faced by remote 
residents. Areas that are disadvantaged in terms of accessibility 
to sleep services are also most disadvantaged in terms of travel 
distance. A significant number of remote areas face this ‘double 
jeopardy’ situation. 
Of note was the greater utilisation of PSG in regional centres along 
the coast of central and northern Queensland. This particularly 
related to the uptake of laboratory-based PSG. Overall, some of 
these centres had levels of PSG uptake per 100,000 adult Medicare 
enrolees equivalent to that of Australian capital cities. Whilst it is 
unclear why this is the case in Queensland and not elsewhere, it 
may in part be related to the type of local industry in these areas. 
These include the mining and defence force sectors where OSA 
may be either prevalent or particularly relevant to work place 
health and safety. Nonetheless, this does not appear to be the 
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case in Western Australia, an area with similarly significant mining 
industry activity. In part this may be explained by a significant 
‘fly-in fly-out’ itinerant workforce in Western Australia, who may be 
more likely to access care for OSA at their distant home address, 
compared with a greater proportion of local and/or adjacent ‘drive-
in drive-out’ residents in Queensland who access PSG locally. 
Marshall et al. speculated that the disparity may arise from a lower 
referral threshold, greater utilisation of PSG for CPAP follow-up, or a 
greater number of service providers in Queensland [26].
Accessibility to PSG may, in part, be a reflection of where specialist 
practices are located. Specialist health care providers are only 
available at a level of 45% and 30% in Inner and Outer Regional 
areas respectively, as in Major Cities, and are even less prevalent in 
remote areas [30]. The ratio of specialists to population in Remote 
and Very Remote areas is 15% and 6% of the rate in Major Cities 
respectively [30]. 
The issue of remoteness is a particular issue for Indigenous 
Australians given a significantly greater proportion of the 
Aboriginal and Torres Strait Islander population resides in Remote 
and Very Remote locations (23.3% compared with only 1.7% 
of non-Indigenous Australians) [20,26-31]. Indigenous health 
disadvantage is well documented and a significant proportion of 
this is attributable to respiratory disease [29]. Although a range 
of social determinants of health contribute to Indigenous health 
disadvantage, accessibility of health care is also a contributing 
factor to Indigenous Australian health inequality. A study of 12 
US rural counties found that the geographical and spatial factors 
of having a drivers licence and distance to health care, and 
predisposing (age, gender, ethnicity) and enabling (socioeconomic 
status) factors were significantly related to rural health care use 
[28]. Thus, the results of the current study indicate that residing in 
remote communities with limited or no public transport options is 
likely to have a particularly significantly impact on Aboriginal and 
Torres Strait Islander peoples’ ability to access PSG. 
The Australian government is committed to ‘Close the Gap’ by 
achieving equity in health status and life expectancy between 
Indigenous and non-Indigenous Australians [32]. Limited access 
to specialist sleep services by Indigenous peoples residing in 
remote areas contributes to continuing poor Indigenous health 
status. Improved access is vital for closing the gap for important 
health outcomes including chronic disease and respiratory illness. 
The provision of specialist medical services to residents of remote 
and sparsely populated Indigenous communities could contribute 
significantly to overcoming the inequity in Indigenous health 
outcomes. In addition, further research is needed to investigate 
potential issues surrounding accessibility to specialist sleep 
services for the 75% of Indigenous persons who do not reside 
in remote areas. Whilst access to PSG may reflect that of broader 
specialist service access this should not in itself be sufficient 
rationale for accepting reduced service delivery for residents of 
regional and remote centres. Nonetheless, enhancing PSG access 
is likely to require an approach combining innovative use of both 
specialist workforce and diagnostic PSG access. 
In relation to the former, specialist access does not necessarily 
require greater numbers of specialists in SDB residing in more 
remote locations. Indeed it is unlikely the small and dispersed 
population in many regions would support such an approach. 
More innovative approaches may include increasing the skills of 
the existing local specialist workforce, who frequently practice 
across a range of specialities, to encompass the management of 
SDB. 
In addition, the expansion of existing specialist outreach programs 
from larger regional and urban centres (e.g., Rural Health 
Outreach Fund [RHOF], Medical Outreach Indigenous Chronic 
Disease [MOICD], Medical Specialist Outreach Assistance Program 
[MSOAP]) to incorporate specialist sleep care, and the support and 
greater utilisation of telehealth or web-based health services, are 
also both likely to facilitate greater accessibility to PSG for those in 
rural and remote locations. 
Telehealth can increase the accessibility of health care delivery by 
bringing health care services into the home. Videoconferencing, 
phone calls or secure online chats with a health care provider is an 
ideal health solution for patients who are geographically isolated. 
Despite the uptake of telehealth services by health care providers, 
Indigenous Australians living in very remote locations may not 
benefit from the use of technology if they do not have access to 
a computer, internet access and a reliable source of electricity, 
or access to a landline or mobile phone and adequate mobile 
coverage. 
Increasing accessibility to diagnostic services for OSA may also 
be achieved without necessarily enhancing local specialist sleep 
service access [33]. We have already shown that in-home PSG has 
expanded significantly in some areas of Australia and expanding 
this to other and more remote areas may enhance PSG accessibility 
[6]. Nonetheless, whether such increased use of in-home PSG 
translates to improved and appropriate uptake of OSA management 
remains a source of debate in Australia [6]. Finally, PSG access may 
be enhanced by utilising existing services more efficiently. In this 
case validation of screening protocols and the use of PSG only as 
a secondary confirmatory test could be considered in line with 
existing evidence of utility of screening systems [6,20,30]. A further 
option to consider is the potential wider use of Type 3 portable 
monitors (limited channel devices usually using 4–7 channels) as 
an alternative to in-laboratory PSG in carefully screened patients 
who have a moderate to high clinical likelihood of OSA and an 
absence of significant comorbid conditions [33,34]. 
Whatever initiatives are undertaken, whether based on specialist 
workforce or PSG access, the key requirement will be that these are 
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demonstrated to translate to cost-effective and equitable access 
and facilitate effective treatment and improved clinical outcomes.
Limitations
These results should be considered in the context of the limitations 
of this study. In 2013/2014 23.8 million people were enrolled 
in Medicare (www.humanservices.gov.au), and as of February 
2015 the resident population of Australia is projected to be 23.7 
million people (www.abs.gov.au) indicating a broad coverage of 
the Australian population. However, some data may be missing 
if Medicare reimbursement of PSG was not claimed. In terms 
of data quality and completeness, the data presented in the GIS 
maps is only as accurate as the Medicare data provided. Medicare 
data were not stratified by diagnostic PSG, repeat PSG studies or 
CPAP studies, therefore a proportion of the PSG provision data 
per 100,000 adult population includes repeat PSG studies and 
CPAP studies. PSG may need to be repeated due to patients being 
unable to sleep for an extended period or electrodes repeatedly 
pulling off. All home-based PSG studies are diagnostic only.
Conclusions
Regional and particularly remote communities in Australia 
experience inequity in health care in general and in relation to 
accessibility to specialist services in particular. Attention needs to 
be given to barriers which may limit equitable access. Diagnostic 
services such as PSG are relatively under-resourced and often 
unavailable in many of Australia’s more remote regions. For 
residents living in regional and remote areas with suspected 
OSA, the cost and time of transport required to access specialist 
and investigation facilities in metropolitan centres appears to be 
a major barrier [29]. We have demonstrated that remoteness itself 
is nonetheless not an invariable driver of reduced accessibility 
as some regions in Australia appear to have high levels of access 
in spite of lower population density and remoteness. A range 
of initiatives targeting specialist accessibility, PSG uptake and 
innovative approaches to OSA diagnosis has been outlined. 
Whichever of these approaches are pursued the key will remain 
ensuring a diagnosis of OSA translates to the uptake of effective 
treatment and improved patient outcome.
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